Showing results (131-140 of 352) with videos related to
Sort By:
Pageof 36
Expert Review of Anticancer Therapy|November 26, 2011
microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinomaAdam E Frampton, Jonathan Krell, Jimmy Jacob, et al.Plos One|March 24, 2018
Novel putative drivers revealed by targeted exome sequencing of advanced solid tumorsAntonio Pannuti, Aleksandra Filipovic, Chindo Hicks, et al.Expert Review of Anticancer Therapy|August 1, 2012
Loss of miR-126 is crucial to pancreatic cancer progressionAdam E Frampton, Jonathan Krell, Jimmy Jacob, et al.International Journal of Cancer|March 10, 2005
Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort studyLaura Waters, Justin Stebbing, Sundhiya Mandalia, et al.Endocrinology, Diabetes & Metabolism Case Reports|March 27, 2018
Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditisPloutarchos Tzoulis, Richard W Corbett, Swarupini Ponnampalam, et al.Clinical Lymphoma & Myeloma|June 16, 2009
Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone diseaseEleftheria Hatzimichael, George Dranitsaris, Aggeliki Dasoula, et al.Antiviral Research|March 10, 2010
Clinical outcome in resistant HIV-2 infection treated with raltegravir and maravirocDarius Armstrong-James, Justin Stebbing, Andrew Scourfield, et al.Oncoimmunology|December 8, 2018
Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trialsQingyuan Huang, Hua Zhang, Josephine Hai, et al.Pharmaceutics|December 5, 2019
Thermosensitive Liposome-Mediated Drug Delivery in Chemotherapy: Mathematical Modelling for Spatio-temporal Drug Distribution and Model-Based OptimisationYu Huang, Boram Gu, Cong Liu, et al.Best Practice & Research. Clinical Endocrinology & Metabolism|August 26, 2015
Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and diseasePaul Cathcart, Walter Lucchesi, Silvia Ottaviani, et al.Pageof 36